Several genome-wide association studies have reported that immune-related genes are involved in AD pathogenesis [194–197], such as CD33, CR1, EPHA1, and MS4A6E/MS4A4E, which regulate the immune system in response to Aβ and activate microglial Aβ degradation. The gene discussed is CD33; the disease is Alzheimer disease.